Holen Sie sich die Stockscreener-App
0.3297
3.48%
0.0111
Vorhandelsmarkt:
.34
0.0103
+3.12%
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks
CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan
Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan
CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - The Globe and Mail
CollPlant Biotechnologies (CLGN) investors approve EGM proposal - Stock Titan
CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.327|Chg%:+0.012 - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.312|Chg%:+0.040 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Cash Flow - TradingKey
TradingKey - TradingKey
Collplant Biotechnologies Ltd (CLGN) Balance Sheet - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.339|Chg%:+0.019 - TradingKey
CollPlant Biotechnologies Ltd. Revenue Breakdown – NASDAQ:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Institutional Confidence - TradingKey
CollPlant Biotechnologies Market Sentiment - Benzinga
CollPlant Biotechnologies (CLGN) completes $10.4M exempt private securities deal - Stock Titan
CollPlant Biotechnologies (CLGN) files to resell 31M shares from 2026 PIPE - Stock Titan
CollPlant Biotechnologies Ltd SEC Filing (Jul 17, 2026) - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CollPlant Biotechnologies files prospectus for 31.047M share offering - scanx.trade
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares - Moomoo
CLGN: Selling Stockholders Plan to Offer 31.05 Million Shares - GuruFocus
CollPlant (CLGN) files F-3 to register 31.05M shares from June 2026 PIPE - Stock Titan
CollPlant Biotechnologies Calls July 29 Extraordinary Meeting to Approve Major Share Capital Increase - The Globe and Mail
CollPlant (NASDAQ: CLGN) targets 500M authorized shares in shareholder vote - Stock Titan
CollPlant Biotechnologies (CLGN) Q4 2025 Earnings: Wider‑Than‑Expected Loss Highlights Pre‑Revenue Challenges - dars.gov.et
CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan
CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus
CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire
CollPlant Biotechnologies Ltd. announced that it expects to receive $2.6 million in funding - marketscreener.com
CollPlant Biotechnologies (CLGN) Q4 2025 earnings summary - Quartr
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to earnings forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBIT forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBITDA forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CollPlant Biotechnologies Ltd Actuals & Estimates (NASDAQ:CLGN) - TradingView
CollPlant Biotechnologies (CLGN) Faces Pressure Near Key SupportKAMA Signal - dars.gov.et
CLGN Technical Analysis & Stock Price Forecast - Intellectia AI
CollPlant Biotechnologies Clings to $0.34 in Low-Volatility ConsolidationRVOL Spike - DonanımHaber
Collplant Biotechnologies Ltd (CLGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CollPlant Heads Toward Nasdaq Deadline With Stock at 40 Cents - Bez Kabli
CollPlant Biotechnologies (CLGN) Holds Near Support Amidst Modest Downside PressureBear Flag - newsline.com
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Sahm
CollPlant Biotechnologies Posts Wider Q1 Loss as It Explores Strategic Alternatives and Advances Regenerative Aesthetics Pipeline - The Globe and Mail
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):